University of Bristol

Academic Institute

Nic TimpsonMs Lynn MolloyDr Kate NorthstoneDr Sue Ring

B3715

The study aims to estimate how many people in ALSPAC have been infected with the virus that causes COVID-19. We don’t know yet if having antibodies gives someone long-lasting protection from the virus. The results of this study may help guide public health policy and the government’s plan for its antibody testing strategy.

This work has the chance to assess antibody response VS infection rate VS clinical presentation in Bristol with a home-based test able also to compare patters in Bristol to those in other (demographically different) cities/areas. Careful interpretation of the data will be required, however this work does have the chance to inform understanding of infection, prevalence, age differences, socio-demographic gradients, life course contributions to outcomes and susceptibility and the utility of this form of testing.

09/02/2021